A research team from Japan investigated whether eradication of H. pylori in peptic ulcer patients prevented gastric cancer. They found that eradication did not significantly reduce the incidence of ...

Eradicating Helicobacter pylori with antibiotics provided significant benefits to primary care patients with functional dyspepsia, randomized trial results showed. Nearly half (49%) of the patients ...

The factors that influence the success of H. pylori treatment include the appropriate drugs, doses, dosing interval, and treatment duration in your local area of practice. A clinician knowledgeable ...

Helicobacter pylori infection is established as the primary aetiological agent in non-cardia gastric cancer, instigating a cascade of chronic gastritis, atrophy and subsequent intestinal metaplasia.

Helicobacter pylori (H. pylori) is an infectious bacterium that resides in the gastric mucosa and causes persistent gastric damage. H. pylori can cause chronic gastritis, peptic ulcers, and iron ...

Improving treatment in H pylori infection could lead to better outcomes in peptic ulcer disease, gastric cancer, gastric lymphoma, and functional dyspepsia. Tetracycline-based bismuth quadruple ...

The management of Helicobacter pylori (H. pylori), a globally prevalent gastric pathogen, has long been centered on its eradication to prevent peptic ulcers, gastric malignancies, and related ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the supplemental new drug application for Talicia for Helicobacter pylori eradication, ...

Using the hydrothermal method, organic polysulfides in garlic were converted into the inorganic polysulfide hydrogen donor FepSM, which was further modified to prepare GAPSR for the adaptation to the ...